Berahyaluronidase Alfa and Pembrolizumab/Bevacizumab/Paclitaxel Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bevacizumab, paclitaxel, and berahyaluronidase alfa and pembrolizumab that can be used in the treatment of ovarian, fallopian tube and primary peritoneal cancers.

**Synonyms:** - Avastin/Taxol/Keytruda Qlex - Berahyaluronidase Alfa and Pembrolizumab-Bevacizumab-Paclitaxel - Berahyaluronidase Alfa and Pembrolizumab/Bevacizumab/Paclitaxel - Berahyaluronidase Alfa-pmph and Pembrolizumab/Bevacizumab/Paclitaxel - Bevacizumab-Paclitaxel-Berahyaluronidase Alfa and Pembrolizumab - Bevacizumab/Berahyaluronidase Alfa and Pembrolizumab/Paclitaxel - Bevacizumab/Paclitaxel/Berahyaluronidase Alfa and Pembrolizumab - Bevacizumab/Paclitaxel/Pembrolizumab and Berahyaluronidase Alfa-pmph - Keytruda Qlex/Avastin/Taxol - Pembrolizumab and Berahyaluronidase Alfa-pmph/Bevacizumab/Paclitaxel